PULSE
Live / Registered — Registered (as of 06 Jan 2026)
What this means for you
Registered since 06 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98298153
- Registration number
- 8091061
- Mark type
- Stylized text
- Filed
- 04 Dec 2023
- Published for opposition
- 03 Dec 2024
- Registered
- 06 Jan 2026
- Attorney of record
- Jessica S. Sachs
Goods and services
- Class 040 — Treatment of materials: Custom manufacturing of cell culture and cell therapy apparatus and equipment for others; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies for others; custom manufacture of cellular therapies; information, advice and consultancy in relation to all the aforesaid
- Class 042 — Scientific and technological services: Platform as a service (PaaS) featuring computer software platforms for developing cell therapies; providing temporary use of web-based software platforms for developing and characterizing cell lines; providing temporary use of non-downloadable computer software platforms for manufacturing cell-based therapies and analyzing data for purposes of process optimization and quality control; laboratory research in the field of biotechnology; scientific research, design and technological development services in the field of biotechnology, for the pharmaceutical and medical industry; scientific research, design and technological development services in the fields of scientific cell cultures, cell therapies, and gene-edited cell therapy equipment and apparatus; scientific research, design and development of manufacturing equipment, manufacturing systems and manufacturing processes in the fields of cell culture, cell therapy, and gene edited cell therapy, for others; scientific consultation services in the field of biotechnology, specifically in relation to cell culture, cell therapy, or gene edited cell therapy manufacturing; providing information with respect to scientific research in the field of stem cells, cell therapy and edited cell gene therapy; calibration of scientific apparatus, machines and equipment used for cell culture, cell therapy and edited cell gene therapy; industrial biotechnology statistical analysis to extract insights from cell line development experiments and data
Owner
- CELYNTRA THERAPEUTICS SA, MONT-SAINT-GUIBERT, BE
- CELYNTRA THERAPEUTICS SA, MONT-SAINT-GUIBERT, BE
- CELYNTRA THERAPEUTICS SA, MONT-SAINT-GUIBERT, BE
- Ncardia B.V., LEIDEN, NL
Prosecution history
- 06 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 12 Dec 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 30 Jun 2025 — NOTICE OF ALLOWANCE CANCELLED
- 01 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jun 2025 — SOU EXTENSION 1 GRANTED
- 30 Jun 2025 — SOU EXTENSION 1 FILED
- 30 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2025 — TEAS DELETE 1(B) BASIS RECEIVED
- 14 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED